AURA BIOSCIENCES INC (AURA) Stock Income Statement
NASDAQ:AURA - Nasdaq - US05153U1079 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 96.12M | 84.99M | 60.30M | 35.25M | 22.21M | |||
| Research and Development | 73.30M | 65.23M | 42.24M | 25.16M | 18.04M | |||
| Selling, General, and Administrative Expenses | 22.81M | 19.76M | 18.06M | 10.09M | 4.16M | |||
| Operating Income | -96.12M | -84.99M | -60.30M | -35.25M | -22.21M | |||
| Interest Income/Expense | 9.43M | 8.59M | 1.86M | 0.00 | 0.00 | |||
| Other Income/Expense | -120.00K | -76.00K | -10.00K | N/A | N/A | |||
| Income Before Taxes | -86.81M | -76.27M | -58.76M | -35.25M | -22.21M | |||
| Income Tax | 112.00K | 137.00K | N/A | N/A | N/A | |||
| Net Income | -86.92M | -76.41M | -58.76M | -46.19M | -30.13M | |||
| EBITDA | -94.89M | -83.70M | -59.12M | -34.42M | -21.38M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.75 | -1.93 | -1.96 | -1.58 | -1.06 | |||
| Non GAAP EPS | -1.75 | -1.98 | -1.99 | N/A | N/A | |||
| Statistics | ||||||||
All data in USD